Accéder directement au contenu Accéder directement à la navigation
Article dans une revue

The Soluble Chain of Interleukin-15 Receptor: A Proinflammatory Molecule Associated with Tumor Progression in Head and Neck Cancer

Abstract : Interleukin (IL)-15 is a proinflammatory cytokine, as it induces the production of inflammatory cytokines [IL-6, tumor necrosis factor alpha (TNFalpha), IL-17, etc.]. A correlation between high intratumoral IL-15 concentrations and poor clinical outcome in lung and head and neck cancer patients has been recently reported. The purpose of this study was to investigate the role of the soluble alpha chain of IL-15 receptor (sIL-15Ralpha), a natural regulator of IL-15, in head and neck cancer. Fifty-three newly diagnosed untreated head and neck cancer patients were included in this study. Quantification of sIL-15Ralpha was performed with a newly developed RIA. Increased serum sIL-15Ralpha concentrations were found in head and neck cancer patients and were closely correlated with poor clinical outcome both in terms of locoregional control and survival even on multivariate analysis. sIL-15Ralpha was mainly produced by tumor cells via proteolytic cleavage of IL-15Ralpha mediated by ADAM-17. A correlation was observed between ADAM-17 expression in tumor cells and serum sIL-15Ralpha concentrations. Surprisingly, sIL-15Ralpha did not act in vitro as an IL-15 antagonist but rather as an enhancer of IL-15-induced proinflammatory cytokines (IL-6, TNFalpha, and IL-17) that may promote tumor progression. This new tumor evasion mechanism based on amplification of the intratumoral inflammatory reaction is probably not restricted to head and neck cancer, as other tumors have been shown to release sIL-15Ralpha. Overall, these results support for the first time an original protumor role of sIL-15Ralpha in cancer.
Type de document :
Article dans une revue
Liste complète des métadonnées

https://hal-enpc.archives-ouvertes.fr/hal-01679874
Contributeur : Laure Garrigue-Antar <>
Soumis le : mercredi 10 janvier 2018 - 11:46:59
Dernière modification le : mercredi 19 août 2020 - 11:17:37

Lien texte intégral

Identifiants

Citation

C. Badoual, G. Bouchaud, E. Agueznay, E. Mortier, S. Hans, et al.. The Soluble Chain of Interleukin-15 Receptor: A Proinflammatory Molecule Associated with Tumor Progression in Head and Neck Cancer. Cancer Research, American Association for Cancer Research, 2008, 68 (10), pp.3907 - 3914. ⟨10.1158/0008-5472.CAN-07-6842⟩. ⟨hal-01679874⟩

Partager

Métriques

Consultations de la notice

332